Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children
Impact of a Beverage Powder Fortified With Multiple Micronutrients (MMN) and Bacopa Monnieri Extract (EBM) on Cognitive Variables in Indian School Children (7-12yrs; Inclusive) After 4 Months of Intervention: a Double Blind, Randomized Controlled Trial
1 other identifier
interventional
310
1 country
1
Brief Summary
The aim of the current study is to investigate the beneficial impact of 4 month consumption of a beverage powder fortified with Brahmi (Bacopa monnieri) extract and multiple vitamins and minerals on short term memory as assessed using standardised cognitive test battery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 9, 2015
CompletedFirst Posted
Study publicly available on registry
April 14, 2015
CompletedJuly 7, 2015
June 1, 2015
6 months
April 9, 2015
July 2, 2015
Conditions
Outcome Measures
Primary Outcomes (2)
'Between errors' in CANTAB task 'Spatial working memory'
'Spatial working memory' task measures the 'Short term memory' (working memory). In this task, participants search through a series of boxes until they find a blue chip, which they move to the "home" area on right side of screen. They then look for the next blue chip but NOT in same box as before. For each problem, the participant must NOT return to a box they have previously found a blue chip in. Number of boxes is gradually increased from 3 to 8. 'Between errors' is defined as times the participant revisits a box in which a token has previously been found. This is calculated for all trials of four or more tokens only. Scale ranges from 0 to 180 with lower score indicating a better performance.
Baseline to 4 months
'Strategy' in CANTAB task 'Spatial working memory'
'Spatial working memory' task measures the 'Short term memory' (working memory). In this task, participants search through a series of boxes until they find a blue chip, which they move to the "home" area on right side of screen. They then look for the next blue chip but NOT in same box as before. Number of boxes is gradually increased from 3 to 8. 'Strategy' is defined as number of distinct boxes used by the participant to begin a new search for a token, within the same problem. Scale ranges from 4 to 28 with a lower score indicating a better performance.
Baseline to 4 months
Secondary Outcomes (6)
'Total errors (adjusted)' in CANTAB task 'Paired associate learning'
Baseline to 4 months
'Problems solved in minimum moves' in CANTAB task 'Stockings of Cambridge'
Baseline to 4 months
'A Prime' in CANTAB task 'Rapid Visual Information Processing'
Baseline to 4 months
'Median latency' in CANTAB task 'Rapid Visual Information Processing'
Baseline to 4 months
'Total false alarms' in CANTAB task 'Rapid Visual Information Processing'
Baseline to 4 months
- +1 more secondary outcomes
Study Arms (2)
Test beverage powder
EXPERIMENTALTest beverage powder is fortified with micronutrients and Bacopa monnieri extract. Each sachet contains 32g of treatmemt product and 6g dairy whitener. Entire content of the sachet will be stirred with 180mL of potable lukewarm water, and given orally twice daily
Control beverage powder
PLACEBO COMPARATORControl beverage powder is the non-fortified isocaloric powder i.e. without micronutrients and Bacopa Monnieri extract. Each sachet contains 32g of placebo product and 6g dairy whitener. Entire content of the sachet will be stirred with 180mL of potable lukewarm water, and given orally twice daily
Interventions
Test beverage powder is fortified with micronutrients and Bacopa monnieri extract. Each sachet contains 32g of treatmemt product and 6g dairy whitener. Entire content of the sachet will be stirred with 180mL of potable lukewarm water, and given orally twice daily
Control beverage powder is the non-fortified isocaloric powder i.e. without micronutrients and Bacopa Monnieri extract. Each sachet contains 32g of placebo product and 6g dairy whitener. Entire content of the sachet will be stirred with 180mL of potable lukewarm water, and given orally twice daily
Eligibility Criteria
You may qualify if:
- Z-score of Body Mass Index (BMI) for age of \>-2 to \<-1
- Participant and participant's parents/legally authorized representatives (LAR) understand and are willing, able and likely to comply with all the study procedures
- Participant is in good general health; has no condition that could affect the safety of participant
You may not qualify if:
- Child in care: A child who is placed under the control/protection of an agency/organization/institution by the court/government
- Allergy/Intolerance/Hypersensitivity any study ingredient
- Severe anaemia (Hb\<8g/dL); Attention Deficit Hyperactivity Disorder; Reading dyslexia or behavioral disorders
- Health condition that could affect food metabolism; any physical or psychiatric illness that could lead to non-completion of study
- Concurrent use of other health food drinks/supplements, within 1 month prior to study start
- Sibling participation in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
- Cambridge Cognition Ltdcollaborator
Study Sites (1)
GSK Investigational Site
Pune, 411001, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2015
First Posted
April 14, 2015
Study Start
July 1, 2014
Primary Completion
January 1, 2015
Study Completion
March 1, 2015
Last Updated
July 7, 2015
Record last verified: 2015-06